Barbieri L.; Bolognesi A.; Valbonesi P.; Polito L.; Olivieri F.; Stirpe F., Polynucleotide: Adenosine glycosidase activity of immunotoxins containing ribosome-inactivating proteins, «JOURNAL OF DRUG TARGETING», 2000, 8, pp. 281 - 288 [Scientific article]
Battelli, M. G.; Bolognesi, A.; Olivieri, F.; Polito, L.; Stirpe, F., Different sensitivity of CD30+ cell lines to Ber-H2/saporin-S6 immunotoxin, «JOURNAL OF DRUG TARGETING», 1998, 5, pp. 181 - 191 [Scientific article]
Bolognesi A.; Tazzari P.L.; Olivieri F.; Polito L.; Lemoli R.; Terenzi A.; Pasqualucci L.; Falini B.; Stirpe F., Evaluation of immunotoxins containing single-chain ribosome- inactivating proteins and an anti-CD22 monoclonal antibody (OM124): In vitro and in vivo studies, «BRITISH JOURNAL OF HAEMATOLOGY», 1998, 101, pp. 179 - 188 [Scientific article]
Vooijs W.C.; Otten H.G.; Van Vliet M.; Van Dijk A.J.G.; De Weger R.A.; De Boer M.; Bohlen H.; Bolognesi A.; Polito L.; De Gast G.C., B7-1 (CD80) as target for immunotoxin therapy for Hodgkin's disease, «BRITISH JOURNAL OF CANCER», 1997, 76, pp. 1163 - 1169 [Scientific article]
Di Massimo A.M.; Di Loreto M.; Pacilli A.; Raucci G.; D'Alatri L.; Mele A.; Bolognesi A.; Polito L.; Stirpe F.; De Santis R., Immunoconjugates made of an anti-EGF receptor monoclonal antibody and type 1 ribosome-inactivating proteins from Saponaria ocymoides or Vaccaria pyramidata, «BRITISH JOURNAL OF CANCER», 1997, 75, pp. 822 - 828 [Scientific article]
Bolognesi A.; Polito L.; Olivieri F.; Valbonesi P.; Barbieri L.; Giulia Bartelli M.; Vittoria Carusi M.; Benvenuto E.; Del Vecchio Blanco F.; Di Maro A.; Parente A.; Di Loreto M.; Stirpe F., New ribosome-inactivating proteins with polynucleotide:adenosine glycosidase and antiviral activities from Basella rubra L. and Bougainvillea spectabilis Willd, «PLANTA», 1997, 203, pp. 422 - 429 [Scientific article]
Battelli M.G.; Barbieri L.; Bolognesi A.; Buonamici L.; Valbonesi P.; Polito L.; Van Damme E.J.M.; Peumans W.J.; Stirpe F., Ribosome-inactivating lectins with polynucleotide:adenosine glycosidase activity, «FEBS LETTERS», 1997, 408, pp. 355 - 359 [Scientific article]
Stirpe F.; Barbieri L.; Gorini P.; Valbonesi P.; Bolognesi A.; Polito L., Activities associated with the presence of ribosome-inactivating proteins increase in senescent and stressed leaves, «FEBS LETTERS», 1996, 382, pp. 309 - 312 [Scientific article]
Terenzi A.; Bolognesi A.; Pasqualucci L.; Flenghi L.; Pileri S.; Stein H.; Marshall K.; Bigerna B.; Polito L.; Tazzari P.L.; Martelli M.F.; Stirpe F.; Falini B., Anti-CD30 (BER-H2) immunotoxins containing the type-1 ribosome-inactivating proteins momordin and PAP-S (pokeweed antiviral protein from seeds) display powerful antitumour activity against CD30+ tumour cells in vitro and in SCID mice, «BRITISH JOURNAL OF HAEMATOLOGY», 1996, 92, pp. 872 - 879 [Scientific article]
Vooijs W.C.; Post J.; Wijdenes J.; Schuurman H.-J.; Bolognesi A.; Polito L.; Stirpe F.; Bast E.J.E.G.; De Gast G.C., Efficacy and toxicity of plasma-cell-reactive monoclonal antibodies B-B2 and B-B4 and their immunotoxins, «CANCER IMMUNOLOGY, IMMUNOTHERAPY», 1996, 42, pp. 319 - 328 [Scientific article]
Battelli M.G.; Buonamici L.; Polito L.; Bolognesi A.; Stirpe F., Hepatotoxicity of ricin, saporin or a saporin immunotoxin: Xanthine oxidase activity in rat liver and blood serum, «VIRCHOWS ARCHIV», 1996, 427, pp. 529 - 535 [Scientific article]
Bolognesi A.; Tazzari P.L.; Olivieri F.; Polito L.; Falini B.; Stirpe F., Induction of apoptosis by ribosome-inactivating proteins and related immunotoxins, «INTERNATIONAL JOURNAL OF CANCER», 1996, 68, pp. 349 - 355 [Scientific article]
Battelli M.G.; Polito L.; Bolognesi A.; Lafleur L.; Fradet Y.; Stirpe F., Toxicity of ribosome-inactivating proteins-containing immunotoxins to a human bladder carcinoma cell line, «INTERNATIONAL JOURNAL OF CANCER», 1996, 65, pp. 485 - 490 [Scientific article]
Pasqualucci, L.; Wasik, M.; Teicher, B. A.; Flenghi, L.; Bolognesi, A.; Stirpe, F.; Polito, L.; Falini, B.; Kadin, M. E., Antitumor activity of anti-CD30 immunotoxin (Ber-H2/saporin) in vitro and in severe combined immunodeficiency disease mice xenografted with human CD30+ anaplastic large-cell lymphoma, «BLOOD», 1995, 85, pp. 2139 - 2146 [Scientific article]
